stars 1 stars 2 stars 3

Using state of the art genetic manipulation techniques to engineer cells, InSCREENeX offers novel, user friendly, mammalian cell systems as decision tools for drug development processes. These complementary, cellular screening tools SCREENflex™ and CI-SCREEN™ aim at all stages of the drug development process. The SCREENflex™ technology creates stable transgenic cell lines 50-70% faster than conventional recombinant techniques. More importantly, the SCREENflex™ cell systems are of unparalleled quality with regard to expression levels and stability of the transgene. The CI-SCREEN™ technology is an enabling tool. It creates physiological relevant cell systems in sufficient quantity for use in drug development campaigns.

InSCREENeX GmbH Questions

Tobias May is the Managing Director of InSCREENeX GmbH.

7 people are employed at InSCREENeX GmbH.

Top InSCREENeX GmbH Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users